PMV Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- PMV Pharmaceuticals's estimated annual revenue is currently $9.6M per year.
- PMV Pharmaceuticals's estimated revenue per employee is $155,000
- PMV Pharmaceuticals's total funding is $236M.
- PMV Pharmaceuticals's current valuation is $798.7M. (January 2022)
Employee Data
- PMV Pharmaceuticals has 62 Employees.
- PMV Pharmaceuticals grew their employee count by 24% last year.
PMV Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, President & CEO | Reveal Email/Phone |
2 | COO and CFO | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | Chief Development Officer | Reveal Email/Phone |
5 | COO & CFO | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | SVP, Drug Discovery and CMC | Reveal Email/Phone |
8 | VP, Information Technology | Reveal Email/Phone |
9 | SVP, Head Corporate Development & Investor Relations | Reveal Email/Phone |
10 | General Counsel & Head Operations | Reveal Email/Phone |
PMV Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is PMV Pharmaceuticals?
PMV Pharma is developing first-in-class p53 regulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.
keywords:N/A
$236M
Total Funding
62
Number of Employees
$9.6M
Revenue (est)
24%
Employee Growth %
$798.7M
Valuation
N/A
Accelerator
PMV Pharmaceuticals News
CRANBURY, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the...
PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53.
PMV Pharmaceuticals is topping up its coffers—just eight months after raising $62 million in its series C round, the cancer biotech is reeling in another $70 million. The capital will advance a suite of candidates targeting p53, a tumor-suppressing protein that is mutated in many cancers. Spons ...
CRANBURY, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations, announced the completion of a $70 million Series D financing round. Avoro Capita ...
It wields a variety of anticancer mechanisms, including DNA repair and programmed cell death. That makes it a very attractive field of research — but it hasn’t yet delivered in the clinic. PMV Pharma plans to change that with a chemistry-centric approach to binding and correcting the function o ...
Other Companies in Cranbury Township
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12M | 83 | -5% | N/A |